ZFIN ChEBI: 3',5'-cyclic purine nucleotide

Relationships

is a type of: cyclic purine nucleotide nucleoside 3',5'-cyclic phosphate

cyclic purine nucleotide nucleoside 3',5'-cyclic phosphate Show first 5 Terms
has subtype: (4Ar,6S,7S,7aR)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol (4aS,6S,7S,7aR)-6-[6-amino-8-[(4-chlorophenyl)thio]-9-purinyl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-ol 1-NO-cAMP 2-(6-aminohexylamino)-cAMP 2-(dimethylamino)-cAMP ... Show All 36 Terms

(4Ar,6S,7S,7aR)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol (4aS,6S,7S,7aR)-6-[6-amino-8-[(4-chlorophenyl)thio]-9-purinyl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-ol 1-NO-cAMP 2-(6-aminohexylamino)-cAMP 2-(dimethylamino)-cAMP 2-amino-8-bromo-9-(2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-6-yl)-3H-purin-6-one 2-Amino-9-(2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-3H-purin-6-one 2-amino-cPuMP 3',5'-cyclic AMP 3',5'-cyclic dAMP 3',5'-cyclic dGMP 3',5'-cyclic GMP 3',5'-cyclic IMP 6-(6-amino-8-bromo-9-purinyl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-ol 6-(dimethylamino)-cPuMP 8-(4-chlorophenylthio)-cAMP 8-(4-chlorophenylthio)-cGMP 8-(6-aminohexylamino)-cAMP 8-(6-aminohexylthio)-cAMP 8-(6-aminohexylthio)-cGMP 8-Br-cAMP 8-bromo-3',5'-cyclic GMP 8-nitroguanosine 3',5'-cyclic monophosphate 8-PIP-cAMP 9-[(4aR,6R,7S)-2-hydroxy-7-methoxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-8-(4-chlorophenyl)sulfanylpurin-6-amine bucladesine Bucladesine sodium butanoic acid [(4aR,7R,7aR)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester butanoic acid [(4aS,6S,7S,7aS)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester butanoic acid [(4aS,7S,7aS)-2-hydroxy-2-oxo-6-[6-oxo-2-(1-oxobutylamino)-3H-purin-9-yl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester butanoic acid [2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester cPuMP N(1)-methyl-cGMP N(2),N(2)-dimethyl-cGMP N(6)-(6-aminohexyl)-cAMP N(6)-butyryl-cAMP Show first 5 Terms

Phenotype

Phenotype resulting from 3',5'-cyclic purine nucleotide

Phenotype where environments contain 3',5'-cyclic purine nucleotide

Phenotype modified by environments containing 3',5'-cyclic purine nucleotide

Human Disease Model